Patheon to seek strategic alternatives as management shuffles

By Lisa Kerner

Charlotte, N.C., Sept. 11 - Patheon, Inc. said its board of directors formed a special committee to evaluate strategic and financial alternatives for the company, in addition to making changes to its management team.

Riccardo Trecroce, Patheon's general counsel and executive vice president, was named interim chief executive officer. The company's chief financial officer and executive vice president, Douglas L. Ludwig, has resigned and will be replaced by Nicholas Dowd, vice president and controller.

The Toronto-based drug-development company also announced its third-quarter financial results, including revenues of $189 million, up from $178.4 million for the year-ago period. Full results will be announced Sept. 15.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.